Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thykamine in mild-to-moderate distal ulcerative colitis
NCT01149707Phase 2Completed
- Sponsor
- PurGenesis Technologies Inc.
- Start
- Jun 2010
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Thykamine in Ulcerative colitis (UC), sponsored by PurGenesis Technologies Inc.. Started Jun 2010; status: completed.
02
Drugs
Thykamine
03
Conditions
Ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01149707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01149707.